title: Peristalsis and fecal pellet propulsion do not require nicotinic, purinergic, 5-HT3, or NK3 receptors in isolated guinea pig distal colon.
abstract: The neuronal mechanism by which distension of the colon triggers peristalsis and the propulsion of colonic contents is incompletely understood. In this study, we used video imaging and spatiotemporal mapping techniques to investigate the neuroneuronal mechanisms underlying peristalsis in isolated guinea pig distal colon. In direct contrast to previous studies, we found that hexamethonium (100 muM-1 mM) or mecamylamine (20 muM) never abolished peristalsis or fecal pellet propulsion, although a temporary blockade of peristalsis was common, giving the impression perhaps that peristalsis was blocked permanently. During the initiation of peristalsis, the intraluminal propulsive force applied to an inserted fecal pellet was significantly reduced by hexamethonium 100 muM, even though, once initiated, the propagation velocity of fecal pellets was never reduced by nicotinic antagonists. In the presence of hexamethonium or mecamylamine, further addition of PPADS (10 muM), ondansetron (1 muM), and SR 142801 (300 nM) had no inhibitory effect on the propagation velocity of fecal pellets. In these preparations, antagonists for nicotinic, purinergic (P2), serotonergic (5-HT3), or tachykinergic (NK3) receptors always abolished responses to the agonists for these receptors, confirming that when peristalsis occurred, nicotinic, P2, 5-HT3, and NK3 receptors were blocked. Tetrodotoxin abolished nonnicotinic peristalsis. In summary, nicotinic transmission contributes to excitatory neuroneuronal transmission underlying peristalsis and fecal pellet propulsion but is not required for peristalsis, nor fecal pellet propulsion, as once thought. These observations could be explained by an excitatory nonnicotinic neuroneuronal pathway that can generate peristalsis and induce normal fecal pellet propagation velocities but does not require nicotinic, P2, 5-HT3, or NK3 receptors.
authors.affiliation: Department of Human Physiology, Flinders University, Adelaide, South Australia, Australia.
authors.forename: Sarah
authors.initials: S
authors.lastname: Nicholas
authors.forename: Nick J
authors.initials: NJ
authors.lastname: Spencer
mesh_terms: D000818:Animals; D003106:Colon / Q000187:drug effects / Q000502:physiology*; D005243:Feces; D006168:Guinea Pigs; D008297:Male; D018733:Nicotinic Antagonists / Q000494:pharmacology; D010528:Peristalsis / Q000187:drug effects / Q000502:physiology*; D058914:Purinergic Antagonists; D011978:Receptors, Nicotinic / Q000378:metabolism*; D011983:Receptors, Purinergic / Q000378:metabolism*; D011985:Receptors, Serotonin / Q000378:metabolism*; D018039:Receptors, Tachykinin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000494:pharmacology
chemical_list: D018733:Nicotinic Antagonists; D058914:Purinergic Antagonists; D011978:Receptors, Nicotinic; D011983:Receptors, Purinergic; D011985:Receptors, Serotonin; D018039:Receptors, Tachykinin; D012702:Serotonin Antagonists